Medical research

Leishmania virulence strategy unveiled

A team from the Institut National de la Recherche Scientifique (INRS) has made a scientific breakthrough regarding the virulence strategy employed by the Leishmania parasite to infect cells of the immune system. This microorganism ...

Diseases, Conditions, Syndromes

Genes key to identifying drug resistant parasites in Brazil

Researchers at the University of York have identified genes in a parasite that could help clinicians predict drug treatment outcomes for patients with visceral leishmaniasis in Brazil.

Diseases, Conditions, Syndromes

INRS takes aim at dreaded tropical disease leishmaniasis

Leishmania is a microorganism that enters the human body via a sandfly bite. The parasite allows itself to be swallowed up by white blood cells to advance its life cycle. The disease threatens the health of over 500 million ...

Diseases, Conditions, Syndromes

Research identifies potential targets for treatment of leishmaniasis

Brazilian researchers at the University of São Paulo's Bioscience Institute (IB-USP) are starting to unravel the molecular mechanisms by which the parasite that causes cutaneous leishmaniasis circumvents the host organism's ...

Diseases, Conditions, Syndromes

Scientists reveal structure of potential leishmaniasis vaccine

Leishmaniasis, caused by the bite of a sand fly carrying a Leishmania parasite, infects around a million people a year around the world. Now, making progress toward a vaccine against the parasitic disease, researchers reporting ...

Diseases, Conditions, Syndromes

Unique strains of Brazilian leishmaniasis set apart by genetics

Some of the roughly 1 million cases a year of the parasitic disease leishmaniasis don't fit with the standard definition of the disease—the patients have unusual symptoms and front-line medicines don't work. Now, researchers ...

page 1 from 3